Oragenics (NYSE:OGEN) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the stock. Oragenics Price Performance Shares of Oragenics stock opened at $0.33 on Tuesday. The company’s 50 day moving average price is $0.34 and its two-hundred day moving average price […]

Leave a Reply

Your email address will not be published.

Previous post VeriSign (NASDAQ:VRSN) Upgraded at StockNews.com
Next post Janone (NASDAQ:ALTS) and Connect Biopharma (NASDAQ:CNTB) Head-To-Head Review